Type 2 diabetic osteoporosis
Conditions
Interventions
Type 2 diabetic osteoporosis group :None
Type 2 diabetic bone loss group :None
Type 2 diabetic normal bone group:None
Normoglycemic Bone Density Loss Group:None
Normoglycemic Osteoporosis Group:None
Sponsors
The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
20 Years to 90 Years
Inclusion criteria
Inclusion criteria: (1) Inclusion criteria for the type 2 diabetes group (1) Meet the diagnostic criteria for diabetes mellitus in the Chinese Guidelines for the Prevention and Treatment of T2DM (2020 Edition); (2) Meet the bone density classification criteria and diagnostic criteria for osteoporosis in the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022); (3) Those who voluntarily participate in and cooperate with the investigation and sign the informed consent form; (4) Persons > 18 years old. Note: Those who meet the above four inclusion criteria at the same time will be included. (2) Inclusion criteria for non-diabetic groups (1) Meet the classification criteria for bone density and the diagnostic criteria for osteoporosis in the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022); (2) Those who voluntarily participate in and cooperate with the investigation and sign the informed consent form; (3) Persons > 18 years old. Note: Those who meet the above three inclusion criteria will be included.
Exclusion criteria
Exclusion criteria: (1) Exclusion criteria for type 2 diabetes group (1) Other types of diabetes except T2DM. Such as: T1DM, special types of diabetes, etc.; (2) Patients with other secondary osteoporosis and diseases affecting bone metabolism. Such as rheumatoid arthritis, hyperthyroidism, hypogonadism, etc.; (3) There are conditions that affect the measurement of bone densitometry. Patients with severe scoliosis; (4) History of anti-osteoporotic drugs, hormones and other drugs affecting bone metabolism in the past 3 months; (5) Patients with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney, hematopoietic system, etc., or serious diseases that affect their survival (such as tumors, etc.); (6) Those who have participated in other clinical trials in the past 3 months. Note: Any of the above items are excluded. (2) Exclusion criteria for non-diabetic groups: (1) Patients with diabetes; (2) Patients with other secondary osteoporosis and diseases affecting bone metabolism. Such as rheumatoid arthritis, hyperthyroidism, hypogonadism, etc.; (3) There are conditions that affect bone density measurement, such as patients with severe scoliosis; (4) Those who have participated in other clinical trials in the past 3 months. Note: Any of the above items are excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone density;Fasting blood glucose;Glycosylated haemoglobin;Fasting serum insulin; | — |
Countries
China
Contacts
Public ContactXiao Yang
The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Outcome results
None listed